Medicare Enrolled
Dr. Kevin Cairns, MD
Pain Medicine · Ft Lauderdale, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cairns from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cairns? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cairns
Dr. Kevin Cairns is a pain medicine in Ft Lauderdale, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cairns performed 8,719 Medicare services across 3,885 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cairns received a total of $51,714 from 53 pharmaceutical and/or device companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cairns is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 14% volume in FL$ $51,714 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,719
Medicare services
Top 14% in FL for pain medicine
3,885
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~459 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,134 | $97 | $260 |
| Physical therapy exercise, per 15 min | 1,604 | $19 | $53 |
| Drug screening test | 527 | $61 | $2,500 |
| X-ray of spine, 1 view | 481 | $20 | $107 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 355 | $112 | $2,500 |
| Injection, methylprednisolone acetate, 80 mg | 330 | $9 | $60 |
| Dexamethasone injection (steroid) | 302 | $0 | $250 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 278 | $227 | $1,368 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 183 | $92 | $819 |
| New patient office visit (45-59 min) | 174 | $125 | $425 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 166 | $180 | $1,177 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 162 | $97 | $690 |
| Joint injection, major joint | 131 | $53 | $244 |
| Manual therapy (hands-on treatment), per 15 min | 115 | $16 | $85 |
| Fluoroscopic guidance for needle placement | 108 | $94 | $500 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 106 | $181 | $1,164 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 101 | $96 | $700 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 97 | $201 | $1,700 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 95 | $360 | $1,847 |
| X-ray of lower and sacral spine, 2-3 views | 87 | $32 | $173 |
| Neuromuscular re-education therapy, per 15 min | 82 | $24 | $80 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 66 | $137 | $750 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 62 | $167 | $1,725 |
| Remote patient monitoring management, 20 min/month | 54 | $39 | $99 |
| X-ray lower and sacral spine, 2-3 views bending views | 51 | $30 | $235 |
| Evaluation for physical therapy, typically 30 minutes | 51 | $77 | $500 |
| Remote patient monitoring device, 30 days | 51 | $40 | $101 |
| Office visit, established patient (20-29 min) | 49 | $73 | $175 |
| X-ray of both hips, 2 views | 46 | $32 | $250 |
| Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming | 45 | $39 | $275 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 43 | $242 | $2,500 |
| X-ray of middle spine, 2 views | 42 | $27 | $144 |
| Injection of substance into middle or upper spine canal using imaging guidance | 39 | $207 | $1,086 |
| Injection of contrast for imaging of hip joint | 37 | $189 | $1,238 |
| Evaluation for physical therapy, typically 20 minutes | 36 | $78 | $500 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $41 | $500 |
| Telephone medical discussion with physician, 5-10 minutes | 35 | $27 | $425 |
| Injection, fentanyl citrate, 0.1 mg | 34 | $1 | $125 |
| Injection, midazolam hydrochloride, per 1 mg | 33 | $0 | $225 |
| Nerve conduction, 7-8 studies | 28 | $139 | $750 |
| Injection of trigger points, 1-2 muscles | 27 | $37 | $238 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 27 | $131 | $548 |
| Injection, cefazolin sodium, 500 mg | 26 | $1 | $9 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 24 | $212 | $1,700 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 23 | $349 | $1,947 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 21 | $1 | $80 |
| Knee X-ray, 3 views | 20 | $36 | $157 |
| X-ray of upper spine, 2-3 views | 18 | $28 | $159 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 16 | $16 | $29 |
| Shoulder X-ray, 2+ views | 14 | $30 | $154 |
| Nerve conduction, 13 or more studies | 13 | $230 | $750 |
| Fusion of spine in lower back | 12 | $1,406 | $9,859 |
| Nerve conduction, 11-12 studies | 12 | $199 | $750 |
| Placement of stabilizing device to back of 1 spine bone in neck | 11 | $681 | $7,459 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
26.2% medium
73.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$51,714
Total received (2018-2024)
Avg $7,388/year across 7 years
Top 3% in FL for pain medicine
53
Companies
592
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,037 (42.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,954 (30.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,723 (26.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$11,201
2023$2,874
2022$3,535
2021$9,032
2020$949
2019$1,912
2018$22,209
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$17,122
BOSTON SCIENTIFIC CORPORATION
$8,195
Nalu Medical, Inc.
$7,773
Vertiflex, Inc.
$6,878
Spinal Simplicity, LLC
$2,232
Medtronic USA, Inc.
$1,469
Medtronic, Inc.
$1,000
Abbott Laboratories
$942
BIOTRONIK NRO, Inc.
$554
Amgen Inc.
$454
Scilex Pharmaceuticals Inc.
$386
Nevro Corp.
$357
Vertos Medical, Inc.
$344
SPR Therapeutics, Inc
$342
Radius Health, Inc.
$294
Stryker Corporation
$284
SCILEX PHARMACEUTICALS INC.
$284
Relievant Medsystems, Inc.
$277
Saluda Medical Americas, Inc.
$252
Stimwave Technologies Incorporated
$218
Almatica Pharma LLC
$194
SI-BONE, INC.
$181
SEASPINE ORTHOPEDICS CORPORATION
$142
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$139
GRT US Holding, Inc.
$124
Electronic Waveform Lab, Inc.
$120
Collegium Pharmaceutical, Inc.
$98
IBSA Pharma Inc.
$98
Horizon Therapeutics plc
$95
Daiichi Sankyo Inc.
$86
Pernix Therapeutics Holdings, Inc.
$84
AstraZeneca Pharmaceuticals LP
$82
Alvogen Inc
$73
PFIZER INC.
$71
Curonix LLC
$58
DePuy Synthes Sales Inc.
$52
Lilly USA, LLC
$46
RedHill Biopharma Inc.
$44
Camber Spine Technologies LLC
$29
Averitas Pharma Inc.
$27
Purdue Pharma L.P.
$26
Masimo Corporation
$24
Mallinckrodt Enterprises LLC
$20
BioDelivery Sciences International, Inc.
$18
Shionogi Inc
$16
Kowa Pharmaceuticals America, Inc.
$16
Sanara MedTech Inc.
$15
Zyla Life Sciences, Inc.
$15
Merit Medical Systems Inc
$14
Sentynl Therapeutics, Inc.
$13
Hikma Pharmaceuticals USA
$13
Allergan, Inc.
$13
Flowonix Medical Incorporated
$11
Top 3 companies account for 64.0% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · Aimovig · BELBUCA · BOTOX · CellerateRx · DUEXIS · ETERNA · EVENITY · Evoke · Evoke SCS · FORTEO · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LICART · LOREEV XR · LYRICA · Levorphanol · Licart · MONOVISC · MOVANTIK · Mariner · Morphabond ER · Movantik · Nalu Neurostimulation System · OFIRMEV · ORTHOVISC · Omnia · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Patient SafetyNet System · Proclaim Family of SCS IPGs · Prolia · Prometra II · Prospera · Protege Family of SCS IPGs · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · SEGLENTIS · SERRATO · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPINEJACK · SPRINT PNS System · SPRIX · SUPERION · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · StabiliT System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TERIPARATIDE · TRITANIUM · Tymlos · VERTAPLEX · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (43%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pain medicine in FL.
Equivalent to $593 per 100 Medicare services performed
Geographic Context
Pain Medicines within 10 mi
16
Per 100K population
0.8
County median income
$74,534
Nearest hospital
HOLY CROSS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cairns is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cairns experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cairns performed 2,134 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cairns receive payments from pharmaceutical companies?
Yes. Dr. Cairns received a total of $51,714 from 53 companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cairns's costs compare to other pain medicines in Ft Lauderdale?
Dr. Cairns's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cairns) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Ft Lauderdale
Browse pain medicines in Ft Lauderdale ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in FL
Pain Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in FL
Which FL pain medicines receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Nalu Medical, Inc. Payments to Doctors
See all physicians who received payments from Nalu Medical, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology